Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 27;15(11):2943.
doi: 10.3390/cancers15112943.

Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital

Affiliations

Adherence to Opioid Patient Prescriber Agreements at a Safety Net Hospital

Soraira Pacheco et al. Cancers (Basel). .

Abstract

Patient prescriber agreements, also known as opioid contracts or opioid treatment agreements, have been recommended as a strategy for mitigating non-medical opioid use (NMOU). The purpose of our study was to characterize the proportion of patients with PPAs, the rate of non-adherence, and clinical predictors for PPA completion and non-adherence. This retrospective study covered consecutive cancer patients seen at a palliative care clinic at a safety net hospital between 1 September 2015 and 31 December 2019. We included patients 18 years or older with cancer diagnoses who received opioids. We collected patient characteristics at consultation and information regarding PPA. The primary purpose was to determine the frequency and predictors of patients with a PPA and non-adherence to PPAs. Descriptive statistics and multivariable logistic regression models were used for the analysis. The survey covered 905 patients having a mean age of 55 (range 18-93), of whom 474 (52%) were female, 423 (47%) were Hispanic, 603 (67%) were single, and 814 (90%) had advanced cancer. Of patients surveyed, 484 (54%) had a PPA, and 50 (10%) of these did not adhere to their PPA. In multivariable analysis, PPAs were associated with younger age (odds ratio [OR] 1.44; p = 0.02) and alcohol use (OR 1.72; p = 0.01). Non-adherence was associated with males (OR 3.66; p = 0.007), being single (OR 12.23; p = 0.003), tobacco (OR 3.34; p = 0.03) and alcohol use (OR 0.29; p = 0.02), contact with persons involved in criminal activity (OR 9.87; p < 0.001), use for non-malignant pain (OR 7.45; p = 0.006), and higher pain score (OR 1.2; p = 0.01). In summary, we found that PPA non-adherence occurred in a substantial minority of patients and was more likely in patients with known NMOU risk factors. These findings underscore the potential role of universal PPAs and systematic screening of NMOU risk factors to streamline care.

Keywords: analgesics; cancer pain; contract; illicit drugs; neoplasm; opioid; opioid-related disorders; pain management; palliative care.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

References

    1. Solano J.P., Gomes B., Higginson I.J. A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease. J. Pain Symptom Manag. 2006;31:58–69. doi: 10.1016/j.jpainsymman.2005.06.007. - DOI - PubMed
    1. Teunissen S.C.C.M., Wesker W., Kruitwagen C., de Haes H.C.J.M., Voest Emile E., de Graeff A. Symptom Prevalence in Patients with Incurable Cancer: A Systematic Review. J. Pain Symptom Manag. 2007;34:94–104. doi: 10.1016/j.jpainsymman.2006.10.015. - DOI - PubMed
    1. Cochran G., Woo B., Lo-Ciganic W., Gordon A.J., Donohue J.M., Gellad W.F. Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review. Subst. Abus. 2015;36:192–202. doi: 10.1080/08897077.2014.993491. - DOI - PMC - PubMed
    1. Bohnert A.S.B., Valenstein M., Bair M.J., Ganoczy D., McCarthy J.F., Ilgen M.A., Blow F.C. Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths. JAMA. 2011;305:1315–1321. doi: 10.1001/jama.2011.370. - DOI - PubMed
    1. de Vries F., Bruin M., Lobatto D.J., Dekkers O.M., Schoones J.W., van Furth W.R., Pereira A.M., Karavitaki N., Biermasz N.R., Najafabadi A.H.Z. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. J. Clin. Endocrinol. Metab. 2020;105:1020–1029. doi: 10.1210/clinem/dgz022. - DOI - PMC - PubMed

LinkOut - more resources